| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.420 | 777 | 2.175 | 2.223 | 276 | 976 | 16.292 | 13.257 | 20.770 | 4.002 |
| Total Income - EUR | 4.420 | 777 | 2.175 | 2.223 | 276 | 976 | 16.292 | 13.257 | 20.770 | 4.002 |
| Total Expenses - EUR | 7.648 | 6.266 | 6.973 | 10.638 | 4.189 | 9.365 | 14.000 | 8.061 | 11.596 | 14.812 |
| Gross Profit/Loss - EUR | -3.228 | -5.489 | -4.798 | -8.415 | -3.913 | -8.389 | 2.292 | 5.195 | 9.174 | -10.810 |
| Net Profit/Loss - EUR | -3.361 | -5.512 | -4.830 | -8.437 | -3.916 | -8.399 | 2.129 | 4.926 | 8.967 | -10.850 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Spitalul 9 Production S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 2.779 | 2.917 | 3.181 | 4.672 | 4.218 | 5.251 | 3.701 | 11.410 | 2.969 | 6.364 |
| Inventories | 0 | 37 | 37 | 36 | 35 | 35 | 0 | 0 | 0 | 0 |
| Receivables | 2.281 | 2.529 | 2.771 | 3.615 | 3.806 | 4.658 | 3.344 | 9.077 | 1.061 | 992 |
| Cash | 498 | 350 | 374 | 1.021 | 377 | 559 | 357 | 2.333 | 1.908 | 5.371 |
| Shareholders Funds | -25.062 | -30.318 | -34.636 | -42.438 | -45.531 | -53.067 | -49.761 | -44.989 | -35.886 | -46.535 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 27.850 | 33.236 | 37.919 | 47.109 | 49.749 | 58.318 | 53.462 | 56.398 | 38.854 | 52.898 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9231 - 9231" | |||||||||
| CAEN Financial Year |
9001
|
|||||||||
Comments - Spitalul 9 Production S.r.l.